TSGA14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.125600E-01
Normal-vs-Stage2
6.642800E-01
Normal-vs-Stage3
9.414400E-02
Normal-vs-Stage4
8.749600E-01
Stage1-vs-Stage2
6.468000E-02
Stage1-vs-Stage3
2.614400E-02
Stage1-vs-Stage4
7.729000E-01
Stage2-vs-Stage3
4.898300E-02
Stage2-vs-Stage4
6.874200E-01
Stage3-vs-Stage4
2.381000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.432800E-01
Normal-vs-AfricanAmerican
9.394400E-01
Normal-vs-Asian
4.366000E-01
Caucasian-vs-AfricanAmerican
9.674800E-01
Caucasian-vs-Asian
1.005040E-01
AfricanAmerican-vs-Asian
2.791800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.404400E-01
Normal-vs-Female
8.780400E-01
Male-vs-Female
3.652600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.842600E-01
Normal-vs-Age(41-60Yrs)
7.170200E-01
Normal-vs-Age(61-80Yrs)
9.147400E-01
Normal-vs-Age(81-100Yrs)
6.157200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.797200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.635200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.386200E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.400300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.037800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.199400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.997200E-01
Normal-vs-Daily Drinker
6.222200E-01
Normal-vs-Weekly Drinker
7.212000E-01
Normal-vs-Occasional Drinker
6.348800E-01
Normal-vs-Social Drinker
6.646000E-01
Non Drinker-vs-Daily Drinker
5.444800E-01
Non Drinker-vs-Weekly Drinker
3.128400E-01
Non Drinker-vs-Occasional Drinker
1.032420E-01
Non Drinker-vs-Social Drinker
1.419000E-01
Daily Drinker-vs-Weekly Drinker
6.950200E-01
Daily Drinker-vs-Occasional Drinker
1.463380E-01
Daily Drinker-vs-Social Drinker
2.003600E-01
Weekly Drinker-vs-Occasional Drinker
1.849760E-01
Weekly Drinker-vs-Social Drinker
2.501800E-01
Occasional Drinker-vs-Social Drinker
8.615600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.147000E-01
Normal-vs-Grade 2
7.892000E-01
Normal-vs-Grade 3
7.195600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.751700E-02
Grade 1-vs-Grade 3
1.863370E-01
Grade 1-vs-Grade 4
5.147000E-01
Grade 2-vs-Grade 3
1.475370E-01
Grade 2-vs-Grade 4
7.892000E-01
Grade 3-vs-Grade 4
7.195600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.565000E-01
Normal-vs-NonDiabetic
9.055800E-01
Diabetic-vs-NonDiabetic
1.884790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.217400E-01
Normal-vs-NoPancreatitis
9.243000E-01
Pancreatitis-vs-NoPancreatitis
1.361980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.343200E-01
Normal-vs-N1
6.756200E-01
N0-vs-N1
6.632300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.206800E-01
Normal-vs-TP53-NonMutant
7.851800E-01
TP53-Mutant-vs-TP53-NonMutant
1.618240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
